A detailed history of Aaron Wealth Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Aaron Wealth Advisors LLC holds 20,176 shares of NVO stock, worth $2.17 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
20,176
Previous 16,057 25.65%
Holding current value
$2.17 Million
Previous $2.29 Million 4.85%
% of portfolio
0.29%
Previous 0.32%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$119.07 - $145.42 $490,449 - $598,984
4,119 Added 25.65%
20,176 $2.4 Million
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $209,588 - $250,922
1,708 Added 11.9%
16,057 $2.29 Million
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $666,471 - $887,149
6,527 Added 83.44%
14,349 $1.84 Million
Q4 2023

Jan 26, 2024

SELL
$87.78 - $105.45 $1.66 Million - $2 Million
-18,960 Reduced 70.79%
7,822 $809,000
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $1.2 Million - $2.63 Million
13,200 Added 97.19%
26,782 $2.44 Million
Q2 2023

Jul 26, 2023

BUY
$155.98 - $172.65 $26,048 - $28,832
167 Added 1.24%
13,582 $2.2 Million
Q1 2023

May 02, 2023

BUY
$132.34 - $159.14 $74,639 - $89,754
564 Added 4.39%
13,415 $2.13 Million
Q4 2022

Jan 24, 2023

BUY
$102.55 - $135.33 $33,431 - $44,117
326 Added 2.6%
12,851 $0
Q3 2022

Oct 21, 2022

BUY
$95.28 - $116.93 $961,470 - $1.18 Million
10,091 Added 414.59%
12,525 $1.25 Million
Q2 2022

Jul 22, 2022

SELL
$103.24 - $121.81 $21.6 Million - $25.5 Million
-209,338 Reduced 98.85%
2,434 $271,000
Q1 2022

May 10, 2022

BUY
$93.1 - $112.54 $19.7 Million - $23.8 Million
211,772 New
211,772 $1.91 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Aaron Wealth Advisors LLC Portfolio

Follow Aaron Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aaron Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aaron Wealth Advisors LLC with notifications on news.